INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Altium Capital Management LP's Holding History (CIK: 0001746382)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 75,000 Value ($000) $6,264 Avg Close — Range —
Q3 2024
Shares 154,000 Value ($000) $11,268 Avg Close — Range —
Q2 2024
Shares 193,000 Value ($000) $13,219 Avg Close — Range —
Q1 2024
Shares 113,000 Value ($000) $7,820 Avg Close — Range —
Q4 2023
Shares 71,000 Value ($000) $5,085 Avg Close — Range —
Q3 2023
Shares 28,000 Value ($000) $1,459 Avg Close — Range —
Q4 2022
Shares 100,000 Value ($000) $5,292 Avg Close — Range —
Q3 2022
Shares 100,000 Value ($000) $4,653 Avg Close — Range —
Q2 2022
Shares 75,000 Value ($000) $4,281 Avg Close — Range —
Q1 2022
Shares 22,500 Value ($000) $1,377 Avg Close — Range —
Q1 2021
Shares 88,326 Value ($000) $2,997 Avg Close — Range —
Q4 2020
Shares 153,348 Value ($000) $4,876 Avg Close — Range —